Put Options

19 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$189.07 - $236.8 $2.46 Million - $3.08 Million
13,000 New
13,000 $2.52 Million
Q1 2024

May 09, 2024

BUY
$212.02 - $267.71 $1.48 Million - $1.87 Million
7,000 New
7,000 $1.51 Million
Q1 2022

May 11, 2022

BUY
$193.77 - $244.14 $9.4 Million - $11.8 Million
48,500 Added 104.98%
94,700 $19.9 Million
Q4 2021

Feb 10, 2022

SELL
$223.92 - $287.77 $1.68 Million - $2.16 Million
-7,500 Reduced 13.97%
46,200 $11.1 Million
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $933,867 - $1.22 Million
3,300 Added 6.55%
53,700 $15.2 Million
Q2 2021

Aug 12, 2021

SELL
$259.0 - $414.71 $4.45 Million - $7.13 Million
-17,200 Reduced 25.44%
50,400 $17.5 Million
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $59.3 Million - $89.3 Million
-251,000 Reduced 78.78%
67,600 $16.6 Million
Q3 2020

Nov 13, 2020

BUY
$264.77 - $305.71 $5.35 Million - $6.18 Million
20,200 Added 6.77%
318,600 $90.4 Million
Q2 2020

Aug 12, 2020

BUY
$258.66 - $342.55 $24.9 Million - $33 Million
96,200 Added 47.58%
298,400 $79.8 Million
Q1 2020

May 13, 2020

BUY
$268.85 - $341.04 $19.7 Million - $24.9 Million
73,100 Added 56.62%
202,200 $64 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $33.6 Million - $46.4 Million
-152,600 Reduced 54.17%
129,100 $38.3 Million
Q3 2019

Nov 12, 2019

SELL
$217.44 - $243.88 $1.98 Million - $2.22 Million
-9,100 Reduced 3.13%
281,700 $65.6 Million
Q2 2019

Aug 12, 2019

SELL
$219.29 - $241.72 $6.25 Million - $6.89 Million
-28,500 Reduced 8.93%
290,800 $68 Million
Q1 2019

May 10, 2019

BUY
$216.71 - $338.96 $48.5 Million - $75.8 Million
223,700 Added 234.0%
319,300 $75.5 Million
Q4 2018

Feb 13, 2019

SELL
$278.5 - $352.75 $10.5 Million - $13.3 Million
-37,800 Reduced 28.34%
95,600 $28.8 Million
Q3 2018

Nov 09, 2018

BUY
$293.51 - $383.83 $12.8 Million - $16.7 Million
43,500 Added 48.39%
133,400 $47.1 Million
Q1 2018

May 09, 2018

BUY
$260.13 - $367.91 $13.8 Million - $19.6 Million
53,200 Added 144.96%
89,900 $24.6 Million
Q4 2017

Feb 09, 2018

SELL
$307.64 - $344.58 $2.8 Million - $3.14 Million
-9,100 Reduced 19.87%
36,700 $11.7 Million
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $12.9 Million - $15.1 Million
45,800
45,800 $14.3 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.